Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Unlock unique experiences with your credit card points. Learn how to make the most of your rewards effectively.
17,266 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
AI data centers demand rock-solid power and long-term service, not hype. This boring industrial stock quietly bankrol...
As Heico reports Q2 2026 results, investors want to know if margins hold and growth remains intact. This article brea...
When a respected lab equipment company posts solid results, investors often respond with enthusiasm. This article unp...
Disney escalates a high-stakes clash with the FCC as ABC stations face early license reviews. A $15 million payment t...
A new study finds immigration restrictions don’t boost native workers and may hamper economic mobility for generation...
ScrollPay Technologies is redefining mobile monetization by paying users for screen time. Deloitte’s fastest-growing ...
Energy markets are shifting as AI data centers demand power and geopolitical risk raises prices. Here are three no-br...
In 2026, some AI-related players outshined Nvidia, delivering eye-popping gains and signaling a broader AI infrastruc...
In a volatile crypto landscape, traders ask whether a $500 XRP bet made in 2026 could vault to five figures by 2030. ...
The software market's laggard this year may be near a tipping point. Snowflake's recent performance hints that AI-dri...
Ford reports a decisive narrowing of EV losses in Q1 2026, lifting full-year guidance and accelerating its energy bus...